IMMUNOMIND
ImmunoMind improves the design of T-cell therapies by precisely identifying T-cell subpopulations and their immune profile. ImmunoMind’s Augmented Intelligence platform guides translational and clinical research to improve the product’s quality, safety and efficacy with single-cell precision. The platform is based on proprietary single-cell multi-omics technologies to automatically evaluate cell differentiation, estimate exhaustion rate of subpopulations and identify off-tumor targets. UC Berkeley SkyDeck’20 Alumnus.
IMMUNOMIND
Industry:
Artificial Intelligence Biotechnology Genetics
Founded:
2018-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.immunomind.io
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
605 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Nginx
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Ainnocence
Ainnocence is a biotech firm engaged in developing an intelligence platform for enhancing drug discovery and development processes.
Applied StemCell
Applied StemCell is a biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics.
Biomiic
Artificial Intelligence platform for next-generation biomarker discovery
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Current Employees Featured
Founder
Investors List
SkyDeck Berkeley
SkyDeck Berkeley investment in Funding Round - ImmunoMind
Official Site Inspections
http://www.immunomind.io
- Host name: 13.107.246.44
- IP address: 13.107.246.44
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ImmunoMind"
ImmunoMind - Crunchbase Company Profile & Funding
Contact Email [email protected] ImmunoMind improves the design of T-cell therapies by precisely identifying T-cell subpopulations and their immune profile. ImmunoMind’s …See details»
ImmunoMind
Early assessment of CAR-T cell populations is critical for improving success in later development stages. With ImmunoMind, you can evaluate CAR-T cells' activation, proliferation, cytotoxicity, …See details»
ImmunoMind. - LinkedIn
ImmunoMind brought essential components of the modern Data Science toolkit for single-cell and bulk immune repertoire analysis – package immunarch, immundata, and others.See details»
ImmunoMind 2025 Company Profile: Valuation, Funding
ImmunoMind General Information Description. Developer of a biotechnology platform designed to support drug development for autoimmune, cancer, and orphan diseases. The company's …See details»
ImmunoMind - Org Chart, Teams, Culture & Jobs - The Org
View ImmunoMind's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. Log in. Sign up. ImmunoMind. Track. Join to …See details»
ImmunoMind Inc. Company Profile | Camden, DE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ImmunoMind Inc. of Camden, DE. Get the latest business insights from Dun & Bradstreet.See details»
Multi-Omics Driven Development of Effective Cell Therapies
ImmunoMind’s Augmented Intelligence platform guides translational and clinical research to improve the product’s quality, safety and efficacy with single-cell precision. ...See details»
ImmunoMind. – Funding, Valuation, Investors, News
ImmunoMind helps select the best T-cell therapy candidates early by assessing and comparing their designs with single-cell precision. ImmunoMind's Augmented Intelligence platform is …See details»
ImmunoMind - VentureRadar
Website: https://www.immunomind.io/ Operator of a biomarker discovery platform dedicated to providing immune-based diagnostics and treatment solutions for viral ...See details»
ImmunoMind - eLabNext
The ImmunoMind add-on identifies both cell subpopulations (e.g. Tscm, Tcm, Tem, Treg, NK, gdT cells) and their characteristics (e.g. exhaustion, senescence, activation) to create a comprehensive profile of CAR-T and other Cell Therapy …See details»
We are delighted to be up and running! - ImmunoMIND
May 20, 2024 ImmunoMIND has been funded by the MRC for 5 years, starting 1 April 2024. We are one of 5 Mental Health Hubs constituting the new national Mental Health Platform. This is …See details»
ImmunoMIND | Mental health platform
The ImmunoMIND Hub wants to develop research which leads to new and precise treatments for SMI, specifically targeting the immune or metabolic systems. In the future, this research could …See details»
Immunomind – Scientific Consulting: An Innovation Revolution for ...
Immunomind is a scientific consulting business established in 2018 to provide biotech companies with a means to get the job done in a streamlined fashion. The modern scientist has …See details»
ImmunoMIND
ImmunoMIND will be a national and international hub of scientists and people with lived experience working openly and transparently together. We will seize the opportunity provided …See details»
ImmunoMind - GitHub
Open-source ecosystem of immune repertoire tools for the development of personalized immunotherapies and vaccines. Built by Vadim Nazarov and the community. - ImmunoMindSee details»
ImmunoMind. posted on LinkedIn
Happy to share that ImmunoMind. has been selected as one of the Hello Tomorrow's Deep Tech Pioneers! I'm glad more and more people see the future of immunotherapies in computational …See details»
ImmunoMind | F6S
ImmunoMind - AI (Artificial Intelligence) - Accelerating cell therapy development. Similar companies Immunai DataMind Srl Advanced Knowledge Discovery Immudicon Cancer …See details»
CAR-T differentiation - immunomind.com
The AI-augmented platform provided by Immunomind allows T cell subpopulations in a CAR-T product to be highlighted, based on the differentiation status. This works for: T-naive cells, T …See details»
О компании «ImmunoMind» - Habr
Компания «ImmunoMind» — профиль работодателя на Хабр Карьере: о компании, фотографии офиса, контакты. Все сервисы Хабра ... immunomind.io. Хочу тут работать ...See details»